Umberto Campia is Section Director, Vascular Medicine and Scientific Lead in Vascular Research, Medstar Heart and Vascular Institute, 110 Irving Street, NW, Ste. 1F1218, Washington DC, United States.
Cardiovascular side effects of cancer treatmentsSubscription
The cardiovascular side effects of cancer treatments remain a challenge in oncologic care. Patients with cancer and cancer survivors have an increased risk of adverse cardiovascular outcomes, including left ventricular (LV) dysfunction, heart failure (HF) and acute coronary events. The treatments most frequently associated with cardiovascular side effects include anthracyclines, monoclonal antibodies (mAbs) targeting the HER2 pathway, and small molecule tyrosine kinase inhibitors (TKIs), in